Modus Therapeutics Holding AB (OSTO:MODTX) Dividends per Share : kr0.00 (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Modus Therapeutics Holding AB Dividends per Share?

Modus Therapeutics Holding AB's dividends per share for the three months ended in Mar. 2025 was kr0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2025 was kr0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2025 was 0.00. As of today, Modus Therapeutics Holding AB's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Modus Therapeutics Holding AB Dividends per Share Historical Data

The historical data trend for Modus Therapeutics Holding AB's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modus Therapeutics Holding AB Dividends per Share Chart

Modus Therapeutics Holding AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dividends per Share

Get a 7-Day Free Trial

Modus Therapeutics Holding AB Quarterly Data
	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Modus Therapeutics Holding AB's Dividends per Share

For the Biotechnology subindustry, Modus Therapeutics Holding AB's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Modus Therapeutics Holding AB's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Modus Therapeutics Holding AB's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Modus Therapeutics Holding AB's Dividend Yield % falls into.

Save Embed

;

Save Embed

;

Modus Therapeutics Holding AB Dividends per Share Calculation

Dividends paid to per common share.

Modus Therapeutics Holding AB (OSTO:MODTX) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Modus Therapeutics Holding AB's Dividend Payout Ratio for the quarter that ended in Mar. 2025 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2025 )	/	EPS without NRI (Q: Mar. 2025 )
	=	0	/	-0.08
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Modus Therapeutics Holding AB Dividends per Share Related Terms

Thank you for viewing the detailed overview of Modus Therapeutics Holding AB's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Modus Therapeutics Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Modus Therapeutics Holding AB (OSTO:MODTX) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

99Z:Germany

Address

Olof Palmes gata 29 IV, Stockholm, SWE, 111 22

Website

https://www.modustx.com

Modus Therapeutics Holding AB is a Swedish clinical biotechnology company developing a treatment for sepsis, endotoxemia, severe malaria, and other disorders with severe systemic inflammation, as well as states of anemia related to chronic inflammation, such as kidney diseases, through its patented polysaccharide, sevuparin. The drug candidate sevuparin has the opportunity to benefit patients and save large healthcare costs.

Modus Therapeutics Holding AB Headlines

No Headlines